| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/22/2013 | WO2013068850A3 PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES |
| 08/22/2013 | WO2013067199A3 Subcutaneous delivery of polymer conjugates of therapeutic agents |
| 08/22/2013 | WO2013064909A3 Crystalline and non-crystalline forms of sglt2 inhibitors |
| 08/22/2013 | WO2013062966A3 Methanol derivatives as trpv3 modulators |
| 08/22/2013 | WO2013059396A3 Treatment of cancer with tor kinase inhibitors |
| 08/22/2013 | WO2013057222A3 Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones |
| 08/22/2013 | WO2012091593A8 Granulates comprising eslicarbazepine acetate |
| 08/22/2013 | WO2012035283A8 Pharmaceutical composition |
| 08/22/2013 | US20130219534 Methods for the Treatment and Prevention of Metabolic Disorders |
| 08/22/2013 | US20130219528 Novel treatment of prostate carcinoma |
| 08/22/2013 | US20130217951 7-(1,2,3-triazol-4-yl) pyrrolo [2,3-b] pyrazine derivatives |
| 08/22/2013 | US20130217949 Combinatorial methods and compositions for treatment of melanoma |
| 08/22/2013 | US20130217913 Antimalarial Drug Comprising Alaremycin or Derivative Thereof as Active Ingredient |
| 08/22/2013 | US20130217857 Erbb interface peptidomimetics and methods of use thereof |
| 08/22/2013 | US20130217782 Orally bioavailable stilbenoids-Compositions and therapeutic applications thereof |
| 08/22/2013 | US20130217781 Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods |
| 08/22/2013 | US20130217779 Methadone chiral isolate as an improved pharmaceutical |
| 08/22/2013 | US20130217778 Methods and compositions for the improvement of skeletal muscle function in a mammal |
| 08/22/2013 | US20130217777 Process for making multiparticulate gastroretentive dosage forms |
| 08/22/2013 | US20130217776 Combination of a Serotonin Reuptake Inhibitor and Agomelatine |
| 08/22/2013 | US20130217775 Treatment of symptoms associated with female gastroparesis |
| 08/22/2013 | US20130217774 Novel process for preparing dexibuprofen ready to compress granules |
| 08/22/2013 | US20130217773 Method and Device for assistance in delivery of medication, and Formulas |
| 08/22/2013 | US20130217772 Ibuprofen intravenous infusion |
| 08/22/2013 | US20130217771 Resolvins: bioemplates for novel therapeutic interventions |
| 08/22/2013 | US20130217770 Method for treating irritable bowel syndrome by administration of chloride channel opener |
| 08/22/2013 | US20130217769 Pharmaceutical semi-solid composition of isotretinoin |
| 08/22/2013 | US20130217763 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality |
| 08/22/2013 | US20130217761 Pharmaceutical Composition Comprising Cinchonains Ia and Ib, Process For Preparing An Epimeric Mixture of Cinchonains Ia and Ib, Use and Method for Reverting/Combating Ventricular Fibrillation |
| 08/22/2013 | US20130217760 Method for enhancing therapeutic effect of anticancer therapies |
| 08/22/2013 | US20130217757 Oncolytic Measles Virus |
| 08/22/2013 | US20130217751 Polynucleotides for reducing respiratory syncytial virus gene expression |
| 08/22/2013 | US20130217750 Cell Growth Inhibitor and Screening Method Thereof |
| 08/22/2013 | US20130217749 Modulation of phosphoenolpyruvate carboxykinase-mitchondrial (pepck-m) expression |
| 08/22/2013 | US20130217747 Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome |
| 08/22/2013 | US20130217744 Efficacy in treating bacterial infections |
| 08/22/2013 | US20130217743 Cancer prevention and treatment methods based on dietary polyamine content |
| 08/22/2013 | US20130217742 Methods and Compositions for Increasing Solubility of Azole Drug Compounds that are Poorly Soluble in Water |
| 08/22/2013 | US20130217741 Topical pharmaceutical compositions for treatment of skin damage |
| 08/22/2013 | US20130217738 Methods and Assays for Detecting and Treating Hypoglycemia |
| 08/22/2013 | US20130217737 Use of Malononitrilamides in Neuropathic Pain |
| 08/22/2013 | US20130217731 Cd38 and obesity |
| 08/22/2013 | US20130217725 Macrocyclic Inhibitors Of Hepatitis C Virus |
| 08/22/2013 | US20130217724 N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof |
| 08/22/2013 | US20130217723 Pharmaceutical Composition Combining Tenatoprazole and an Anti-Inflammatory Agent |
| 08/22/2013 | US20130217722 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 08/22/2013 | US20130217721 Compositions and methods for detection and treatment of b-raf inhibitor-resistant melanomas |
| 08/22/2013 | US20130217719 Combination of Organic Compounds |
| 08/22/2013 | US20130217718 Treatment of progressive neurodegerative disease with ibudilast |
| 08/22/2013 | US20130217717 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 08/22/2013 | US20130217716 Pharmaceutical Formulation Containing Gelling Agent |
| 08/22/2013 | US20130217715 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents |
| 08/22/2013 | US20130217714 Non-Flushing Niacin Analogues, and Methods of Use Thereof |
| 08/22/2013 | US20130217711 Use of a Receptor-Type Kinase Modulator for Treating Polycystic Kidney Disease |
| 08/22/2013 | US20130217710 Methods for treating cancer |
| 08/22/2013 | US20130217709 Cyclic Amine Azaheterocyclic Carboxamides |
| 08/22/2013 | US20130217707 Treating attention deficit hyperactivity disorder with nhe inhibitors |
| 08/22/2013 | US20130217699 Parasiticidal dihydroisoxazole compounds |
| 08/22/2013 | US20130217696 Methods for the treatment of erectile dysfunction using fispemifene |
| 08/22/2013 | US20130217695 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/22/2013 | US20130217694 Method of reducing the severity of inflammatory dermatological conditions |
| 08/22/2013 | US20130217691 Compositions and Methods for Treating Hyperproliferative Disorders |
| 08/22/2013 | US20130217690 Novel 3-hydroxyisothiazole 1-oxide derivatives |
| 08/22/2013 | US20130217687 Arylsulfonamide ccr3 antagonists |
| 08/22/2013 | US20130217683 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof |
| 08/22/2013 | US20130217681 Method and composition for weight-gain management |
| 08/22/2013 | US20130217679 Compositions and Methods for Treatment of Neurodegenerative Disease |
| 08/22/2013 | US20130217677 5ht2c receptor modulator compositions and methods of use |
| 08/22/2013 | US20130217676 5ht2c receptor modulators |
| 08/22/2013 | US20130217673 Mixed monoamine reuptake inhibitor in a biodegradable polymer carrier |
| 08/22/2013 | US20130217664 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 08/22/2013 | US20130217660 Novel prolylcarboxypeptidase inhibitors |
| 08/22/2013 | US20130217658 Pyrazole compounds acting against allergic, inflammatory and immune disorders |
| 08/22/2013 | US20130217657 Combination anti-inflammatory ophthalmic compositions |
| 08/22/2013 | US20130217655 Compositions for treating psoriasis of the scalp |
| 08/22/2013 | US20130217654 Surfactant Lipids, Compositions Thereof, and Uses Thereof |
| 08/22/2013 | US20130217653 Formulations of canfosfamide and their preparation |
| 08/22/2013 | US20130217647 Biomarkers for Prostate Cancer and Methods Using the Same |
| 08/22/2013 | US20130217646 Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350 |
| 08/22/2013 | US20130217645 Compounds and Compositions for the Treatment of Cancer |
| 08/22/2013 | US20130217644 Pharmaceutical Compositions of 2'-C-Methyl-Guanosine, 5'-[2[(3-Hydroxy-2,2-Dimethyl-1-Oxopropyl)Thio]Ethyl N-(Phenylmethyl)Phosphoramidate] |
| 08/22/2013 | US20130217641 Compositions for treating helicobacter pylori infection |
| 08/22/2013 | US20130217639 Compound for activating natural killer t cells and preparing method thereof |
| 08/22/2013 | US20130217615 Combination treatment of major depressive disorder |
| 08/22/2013 | US20130217098 Production of isoprenoids |
| 08/22/2013 | US20130216634 Herbal Supplement Prepared From Pelargonium Citronellum |
| 08/22/2013 | US20130216630 Biomaterials for use in methods of bone replacement therapy |
| 08/22/2013 | US20130216625 Treatment of insulin resistance or diseases associated with insulin resistance |
| 08/22/2013 | US20130216624 Sustained-release pellets containing tacrolimus as an active ingredient |
| 08/22/2013 | US20130216620 Extended-release formulation for reducing the frequency of urination and method of use thereof |
| 08/22/2013 | US20130216617 Pharmaceutical compositions of (r)-lansoprazole |
| 08/22/2013 | US20130216615 Pharmaceutical Compositions Containing Dimethyl Fumarate |
| 08/22/2013 | US20130216614 Immunogenic compositions and methods for treating nuerologic disorders |
| 08/22/2013 | US20130216608 Airway Administration of Angiogenesis Inhibitors |
| 08/22/2013 | US20130216606 Liposomal formulation for ocular drug delivery |
| 08/22/2013 | US20130216605 Micro-rnas modulating immunity and inflammation |
| 08/22/2013 | US20130216604 Polypeptide for inhibiting metastasis, uses thereof, and pharmaceutical compositions containing the same |
| 08/22/2013 | US20130216593 Systems, methods, and devices for plasmid gene transfection using polymer-modified microbubbles |
| 08/22/2013 | US20130216590 Topical antiviral formulations for prevention of transmission of hsv-2 |
| 08/22/2013 | US20130216586 Animal feed compositions and methods of using the same |